2021 annual financial data
Cardiol Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -37,822.25%.
Operating income was -30,568,391 CAD and net income was -25,013,195 CAD.
Operating cash flow was -23,550,779 CAD.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 62,267 CAD
- Operating income
- -30,568,391 CAD
- Net income
- -25,013,195 CAD
- Operating cash flow
- -23,550,779 CAD